Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 875 of 3173 entries
View as:

Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate

Phase: N/A Priority: Normal
NCT ID: NCT00139061 Org: User:
Start: 03/31/05 End: 05/31/06 Due: 05/31/07

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05525910 Org: User:
Start: 08/31/22 End: 11/07/22 Due: 11/07/23

A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06782282 Org: User:
Start: 01/20/25 End: 09/30/25 Due: 09/30/26

A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.

Phase: N/A Priority: Normal
NCT ID: NCT05896163 Org: User:
Start: 08/30/23 End: 09/27/28 Due: 09/27/29

A Study To Investigate The Elimination Of PF-06273588 From The Body Following A Single Low Dose.

Phase: N/A Priority: Normal
NCT ID: NCT01408355 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Phase: N/A Priority: Normal
NCT ID: NCT00605280 Org: User:
Start: 09/30/05 End: 07/31/11 Due: 07/31/12

Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

Phase: N/A Priority: Normal
NCT ID: NCT05046613 Org: User:
Start: 09/23/21 End: 04/30/34 Due: 04/30/35

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Phase: N/A Priority: Normal
NCT ID: NCT04517864 Org: User:
Start: 09/15/20 End: 05/07/24 Due: 05/07/25

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00026273 Org: User:
Start: 01/31/01 End: - Due: -

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Phase: N/A Priority: Normal
NCT ID: NCT06807268 Org: User:
Start: 06/30/25 End: 05/02/27 Due: 05/02/28

Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01602341 Org: User:
Start: 08/31/12 End: 01/31/13 Due: 01/31/14

A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

Phase: N/A Priority: Normal
NCT ID: NCT05745142 Org: User:
Start: 02/23/23 End: 02/23/23 Due: 02/23/24

Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa

Phase: N/A Priority: Normal
NCT ID: NCT00677833 Org: User:
Start: 06/30/08 End: 09/30/10 Due: 09/30/11

A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT03362502 Org: User:
Start: 01/23/18 End: 08/29/25 Due: 08/29/26

ATGAM General Investigation

Phase: N/A Priority: Normal
NCT ID: NCT06039020 Org: User:
Start: 02/21/24 End: 01/22/27 Due: 01/22/28

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05317416 Org: User:
Start: 03/25/22 End: 10/31/29 Due: 10/31/30

An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01939548 Org: User:
Start: 10/31/13 End: 10/31/14 Due: 10/31/15

Assessment of the Analgesic Effects of PF-06273340 in Healthy Volunteers Using Evoked Pain Endpoints

Phase: N/A Priority: Normal
NCT ID: NCT02260947 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00141388 Org: User:
Start: 07/31/98 End: 10/31/05 Due: 10/31/06

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02265718 Org: User:
Start: 09/30/14 End: 05/31/16 Due: 05/31/17

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03794154 Org: User:
Start: 03/30/20 End: 06/05/20 Due: 06/05/21

Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00445770 Org: User:
Start: 07/31/06 End: 07/31/10 Due: 07/31/11

A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02487433 Org: User:
Start: 06/30/15 End: 07/31/15 Due: 07/31/16

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00037804 Org: User:
Start: - End: - Due: -

Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.

Phase: N/A Priority: Normal
NCT ID: NCT00858208 Org: User:
Start: 03/31/08 End: 04/30/11 Due: 04/30/12